Jaimie P Meyer1, Javier Cepeda1, Faye S Taxman1, Frederick L Altice1. 1. Jaimie P. Meyer and Frederick L. Altice are with the AIDS Program, Yale School of Medicine, New Haven, CT. Jaimie P. Meyer is also with the Chronic Disease Epidemiology Department, Yale School of Public Health, New Haven. Javier Cepeda and Frederick L. Altice are with the Department of Epidemiology of Microbial Diseases, Yale School of Public Health. Faye S. Taxman is with the Criminology, Law, and Society Department, George Mason University, Fairfax, VA.
Abstract
OBJECTIVES: We evaluated sex-related differences in HIV and criminal justice (CJ) outcomes. METHODS: We quantified sex-related differences in criminal offenses, incarcerations, and HIV outcomes among all HIV-infected inmates on antiretroviral therapy (ART) in Connecticut (2005-2012). Computed criminogenic risk scores estimated future CJ involvement. Stacked logistic regression models with random effects identified significant correlates of HIV viral suppression on CJ entry, reflecting preceding community-based treatment. RESULTS: Compared with 866 HIV-infected men on ART (1619 incarcerations), 223 women (461 incarcerations) were more likely to be younger, White, and medically insured, with shorter incarceration periods (mean = 196.8 vs 368.1 days), mostly for public disorder offenses. One third of both women and men had viral suppression on CJ entry, correlating positively with older age and having treated comorbidities. Entry viral suppression inversely correlated with incarceration duration for women and with criminogenic risk score for men. CONCLUSIONS: In the largest contemporary cohort of HIV-infected inmates on ART, women's higher prevalence of nonviolent offenses and treatable comorbidities supports alternatives to incarceration strategies. Sex-specific interventions for CJ populations with HIV effectively align public health and safety goals.
OBJECTIVES: We evaluated sex-related differences in HIV and criminal justice (CJ) outcomes. METHODS: We quantified sex-related differences in criminal offenses, incarcerations, and HIV outcomes among all HIV-infected inmates on antiretroviral therapy (ART) in Connecticut (2005-2012). Computed criminogenic risk scores estimated future CJ involvement. Stacked logistic regression models with random effects identified significant correlates of HIV viral suppression on CJ entry, reflecting preceding community-based treatment. RESULTS: Compared with 866 HIV-infectedmen on ART (1619 incarcerations), 223 women (461 incarcerations) were more likely to be younger, White, and medically insured, with shorter incarceration periods (mean = 196.8 vs 368.1 days), mostly for public disorder offenses. One third of both women and men had viral suppression on CJ entry, correlating positively with older age and having treated comorbidities. Entry viral suppression inversely correlated with incarceration duration for women and with criminogenic risk score for men. CONCLUSIONS: In the largest contemporary cohort of HIV-infected inmates on ART, women's higher prevalence of nonviolent offenses and treatable comorbidities supports alternatives to incarceration strategies. Sex-specific interventions for CJ populations with HIV effectively align public health and safety goals.
Authors: Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer Journal: JAMA Intern Med Date: 2014-05 Impact factor: 21.873
Authors: Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser Journal: Health Serv Res Date: 2006-02 Impact factor: 3.402
Authors: Amy L Althoff; Alexei Zelenev; Jaimie P Meyer; Jeannia Fu; Shan-Estelle Brown; Panagiotis Vagenas; Ann K Avery; Jacqueline Cruzado-Quiñones; Anne C Spaulding; Frederick L Altice Journal: AIDS Behav Date: 2013-10
Authors: Jaimie P Meyer; Javier Cepeda; Sandra A Springer; Johnny Wu; Robert L Trestman; Frederick L Altice Journal: Lancet HIV Date: 2014-11-01 Impact factor: 12.767
Authors: Jacques Baillargeon; Thomas P Giordano; Josiah D Rich; Z Helen Wu; Katherine Wells; Brad H Pollock; David P Paar Journal: JAMA Date: 2009-02-25 Impact factor: 56.272
Authors: Darrell J Gaskin; Roland J Thorpe; Emma E McGinty; Kelly Bower; Charles Rohde; J Hunter Young; Thomas A LaVeist; Lisa Dubay Journal: Am J Public Health Date: 2013-11-14 Impact factor: 9.308
Authors: Kelsey B Loeliger; Mary L Biggs; Rebekah Young; David W Seal; Curt G Beckwith; Irene Kuo; Michael S Gordon; Frederick L Altice; Lawrence J Ouellet; William E Cunningham; Jeremy D Young; Sandra A Springer Journal: AIDS Behav Date: 2017-10
Authors: Maxim Polonsky; Julia Rozanova; Lyuba Azbel; Chethan Bachireddy; Jacob Izenberg; Tetiana Kiriazova; Sergii Dvoryak; Frederick L Altice Journal: AIDS Behav Date: 2016-12
Authors: Margaret Erickson; Kate Shannon; Ariel Sernick; Neora Pick; Flo Ranville; Ruth E Martin; Andrea Krüsi Journal: AIDS Date: 2019-01-27 Impact factor: 4.177
Authors: Josiah D Rich; Curt G Beckwith; Alexandria Macmadu; Brandon D L Marshall; Lauren Brinkley-Rubinstein; Joseph J Amon; M-J Milloy; Maximilian R F King; Jorge Sanchez; Lukoye Atwoli; Frederick L Altice Journal: Lancet Date: 2016-07-14 Impact factor: 79.321
Authors: Frederick L Altice; Lyuba Azbel; Jack Stone; Ellen Brooks-Pollock; Pavlo Smyrnov; Sergii Dvoriak; Faye S Taxman; Nabila El-Bassel; Natasha K Martin; Robert Booth; Heino Stöver; Kate Dolan; Peter Vickerman Journal: Lancet Date: 2016-07-14 Impact factor: 79.321
Authors: Putu Duff; Kate Shannon; Melissa Braschel; Flo Ranville; Mary Kestler; Ruth Elwood Martin; Andrea Krüsi; Kathleen Deering Journal: Int J STD AIDS Date: 2020-12-08 Impact factor: 1.359